Pharmaceutical

J&J’s Darzalex combination gains expanded label for multiple myeloma in Europe

Darzalex will now be available to patients with newly diagnosed multiple myeloma eligible for autologous stem cell transplant.

Oct 24, 2024 - 04:00
J&J’s Darzalex combination gains expanded label for multiple myeloma in Europe
Darzalex will now be available to patients with newly diagnosed multiple myeloma eligible for autologous stem cell transplant.
Read the original article

Tags:

Previous Article

Be Bio raises $82m to advance haemophilia B gene therapy to Phase I/II trial

Next Article

FDA expands Pfizer’s RSV vaccine label to include all high-risk adults

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Here’s what you might have missed in Biden’s budget proposal

STAT+: Here’s what you might have missed in Biden’s bud...

Mar 13, 2024

Researchers use AI to measure recovery from treatment-resistant depression

Researchers use AI to measure recovery from treatment-r...

Sep 20, 2023

STAT+: For brain-computer interfaces, the commercial hurdles may be bigger than scientific ones

STAT+: For brain-computer interfaces, the commercial hu...

Aug 5, 2023